tirzepatide latest news Obesity drug seen as effective for long COVID, gets clinical trial #Zepbound (#tirzepatide aka #mounjaro) just

Mounjaro and Ozempic are both GLP-1 receptor agonists used for blood sugar control and weight loss, but Mounjaro also targets the GIP receptor, which may lead to greater weight loss and improved blood sugar regulation

Utilizing just a smartphone, tablet, or computer, initiate a discussion with one of our expert semaglutide providers

Sustainable weight loss Preserve lean muscle Better blood sugar control Up to 15-20% average weight loss About Tirzepatide Weight Loss Service Achieve your weight loss goals with our personalized Tirzepatide Weight Loss Program

Neuroscience (2015) 300:7584

Acknowledgements This work was supported by the National Natural Science Foundation of China (U2230123, 31900984, 81972901, 82304969, 82304789), the National Key Research and Development Program of China (2020YFC2005500), the Central Guide Local Science and Technology Development Fund (2022ZYD0080), the Key Research and Development Program of Science and Technology Department of Sichuan Province (2023YFS0110, 2023YFS0125, 2023YFS0131, 2023NSFSC0033, 2022YFS0159, 2022YFS0606, 2019YFS0514), and China Postdoctoral Science Foundation (2022M710623, 2022M720670)